0000897069-23-001844.txt : 20231227 0000897069-23-001844.hdr.sgml : 20231227 20231227145920 ACCESSION NUMBER: 0000897069-23-001844 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20231227 DATE AS OF CHANGE: 20231227 EFFECTIVENESS DATE: 20231227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TuHURA Biosciences, Inc. CENTRAL INDEX KEY: 0001252142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 593359711 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500849 FILM NUMBER: 231517599 BUSINESS ADDRESS: STREET 1: 4613 N CLARK AVENUE CITY: TAMPA STATE: FL ZIP: 33614 BUSINESS PHONE: 8132880014 MAIL ADDRESS: STREET 1: 4613 N CLARK AVENUE CITY: TAMPA STATE: FL ZIP: 33614 FORMER COMPANY: FORMER CONFORMED NAME: MORPHOGENESIS INC DATE OF NAME CHANGE: 20030703 D 1 primary_doc.xml X0708 D LIVE 0001252142 TuHURA Biosciences, Inc. 10500 University Center Drive TAMPA FL FLORIDA 33612 813-875-6600 DELAWARE MORPHOGENESIS INC Corporation true 2023 James Bianco 10500 University Center Drive Tampa FL FLORIDA 33612 Executive Officer Director Dan Dearborn 10500 University Center Drive Tampa FL FLORIDA 33612 Executive Officer Kiran Patel 10500 University Center Drive Tampa FL FLORIDA 33612 Director George Ng 10500 University Center Drive Tampa FL FLORIDA 33612 Director Michael Lawman 10500 University Center Drive Tampa FL FLORIDA 33612 Director Patricia Lawman 10500 University Center Drive Tampa FL FLORIDA 33612 Director Alan List 10500 University Center Drive Tampa FL FLORIDA 33612 Director James Manuso 10500 University Center Drive Tampa FL FLORIDA 33612 Director Biotechnology Decline to Disclose 06c false 2023-12-11 false true true true false 0 Paulson Investment Company LLC 5670 None None 10220 SW Greenburg Road Suite 380 Portland OR OREGON 97223 All States false 15000000 1665000 13335000 false 8 133200 true 0 Paulson Investment Company, LLC ("Paulson") will be paid a cash placement fee equal to 6% of gross proceeds of Offering. Issuer will also issue to Paulson a number of shares of Common Stock equal to 2% of the gross proceeds of Offering divided by 1.5. 0 false TuHURA Biosciences, Inc. /s/ Dan Dearborn Dan Dearborn Chief Financial Officer 2023-12-27